Posted by admin on Apr 18th, 2022

Teleflex Incorporated (NYSE:TFX – Get Rating) was the target of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 484,800 shares, a decline of 23.1% from the March 15th total of 630,200 shares. Based on an average daily volume of 330,700 shares, the short-interest ratio is currently 1.5 days.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Allworth Financial LP lifted its stake in shares of Teleflex by 144.4% in the 4th quarter. Allworth Financial LP now owns 110 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 65 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. lifted its stake in shares of Teleflex by 62.9% in the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 114 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 44 shares during the last quarter. Aquire Wealth Advisors LLC bought a new stake in shares of Teleflex in the 4th quarter valued at approximately $38,000. Spire Wealth Management lifted its stake in shares of Teleflex by 3,900.0% in the 4th quarter. Spire Wealth Management now owns 120 shares of the medical technology company’s stock valued at $40,000 after purchasing an additional 117 shares during the last quarter. Finally, Ten Capital Wealth Advisors LLC bought a new stake in shares of Teleflex in the 4th quarter valued at approximately $43,000. Institutional investors and hedge funds own 91.86% of the company’s stock.

TFX has been the subject of several recent research reports. Needham & Company LLC cut their price target on Teleflex from $425.00 to $400.00 and set a “buy” rating for the company in a report on Monday, January 31st. StockNews.com initiated coverage on Teleflex in a report on Thursday, March 31st. They set a “buy” rating for the company. Truist Financial initiated coverage on Teleflex in a report on Tuesday, April 12th. They set a “hold” rating and a $370.00 price target for the company. Raymond James cut their price target on Teleflex from $391.00 to $370.00 and set an “outperform” rating for the company in a report on Wednesday, February 23rd. Finally, Morgan Stanley cut their price target on Teleflex from $383.00 to $378.00 and set an “equal weight” rating for the company in a report on Friday, February 25th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $397.08.

Shares of NYSE TFX traded down $4.32 during mid-day trading on Monday, reaching $332.30. The company’s stock had a trading volume of 1,814 shares, compared to its average volume of 326,936. The firm has a market capitalization of $15.59 billion, a PE ratio of 32.87, a P/E/G ratio of 1.85 and a beta of 1.06. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.10 and a quick ratio of 1.40. The stock has a fifty day moving average of $337.36 and a two-hundred day moving average of $335.44. Teleflex has a 52 week low of $289.00 and a 52 week high of $449.38.

Teleflex (NYSE:TFX – Get Rating) last announced its quarterly earnings results on Thursday, February 24th. The medical technology company reported $3.60 EPS for the quarter, beating analysts’ consensus estimates of $3.53 by $0.07. The company had revenue of $761.90 million during the quarter, compared to analyst estimates of $749.60 million. Teleflex had a return on equity of 17.74% and a net margin of 17.28%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the company earned $3.25 earnings per share. Analysts anticipate that Teleflex will post 14 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 15th. Shareholders of record on Monday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.41%. The ex-dividend date was Friday, March 4th. Teleflex’s dividend payout ratio is presently 13.28%.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Short Interest in Aberdeen Income Credit Strategies Fund (NYSE:ACP) Declines By 22.9%

Brandywine Realty Trust (NYSE:BDN) Short Interest Down 23.5% in March